Globus Medical, Inc.
GMED
$85.90
-$0.04-0.05%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 535.43M | 586.71M | 537.87M | 423.78M | 356.65M |
| Total Depreciation and Amortization | 279.56M | 280.65M | 276.42M | 274.65M | 270.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 198.35M | 15.66M | 5.95M | 34.79M | 26.83M |
| Change in Net Operating Assets | -102.95M | -104.51M | -66.80M | -18.02M | 15.09M |
| Cash from Operations | 910.39M | 778.51M | 753.45M | 715.20M | 669.16M |
| Capital Expenditure | -154.80M | -168.19M | -164.68M | -135.59M | -141.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -6.41M | -257.46M | -257.55M | -257.55M | -257.65M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -337.81M | -243.43M | 67.21M | 45.45M | 112.56M |
| Cash from Investing | -499.01M | -669.07M | -355.01M | -347.69M | -286.81M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | -449.99M | -449.99M | -449.99M |
| Issuance of Common Stock | 110.77M | 104.50M | 89.76M | 96.28M | 108.71M |
| Repurchase of Common Stock | -224.47M | -114.06M | -303.36M | -259.08M | -220.18M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.43M | -16.01M | -15.57M | -19.86M | -19.56M |
| Cash from Financing | -135.13M | -25.57M | -679.16M | -632.64M | -581.02M |
| Foreign Exchange rate Adjustments | 2.05M | 15.81M | 22.45M | 14.13M | 17.69M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 278.30M | 99.68M | -258.28M | -251.00M | -180.98M |